MedTrace Logo

The Efficacy of Pasteurised Akkermansia Muciniphila in Healthy Medical Workers

NCT05738746 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 202

Last updated 2025-03-18

No results posted yet for this study

Summary

Gut microbiota alterations secondary to chronic stress might serve as a triggering factor towards manifestation of somatic and mental symptoms. The administration of pasteurised A. muciniphila MucT has the capability of supporting microbiota and improving the gut barrier integrity, which might lead to decrease of inflammation and the negative health consequences of stress in healthy participants.

Conditions

  • Stress
  • Healthy
  • Dietary Supplement

Interventions

DIETARY_SUPPLEMENT

Pasteurized Akkermansia muciniphila

PAM supplementation; packaging will be given to the subjects every one month during follow-up visits, with the instructions to take one dose every morning on an empty stomach

DIETARY_SUPPLEMENT

Placebo

PBO administration; packaging will be given to the subjects every one month during follow-up visits, with the instructions to take one dose every morning on an empty stomach

Sponsors & Collaborators

  • SANPROBI SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA SPOLKA KOMANDYTOWA

    collaborator UNKNOWN

  • THE AKKERMANSIA COMPANY

    collaborator UNKNOWN

  • Charite University, Berlin, Germany

    collaborator OTHER

  • MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (MDC) - MDC

    collaborator UNKNOWN

  • Imperial College London

    collaborator OTHER

  • Pomeranian Medical University Szczecin

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-24
Primary Completion
2025-03-10
Completion
2025-03-10

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05738746 on ClinicalTrials.gov